2024³â 12¿ù 27ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Uniphore and Konecta Join Forces to Advance AI in Customer Experience and Digital Transformation

Partnership is the first to deliver a real solution for scaling generative AI globally
´º½ºÀÏÀÚ: 2024-12-03

PALO ALTO, CALIF. & MADRID -- Uniphore, a global AI leader with the only end-to-end Enterprise AI architecture that delivers unmatched customer focused solutions, together with Konecta, a global leader in customer experience (CX) and digital services, announced a strategic alliance that will create and accelerate true AI-powered value worldwide. This is a significant first in the evolution of Enterprise AI with two industry leaders coming together to deliver real ROI through scalable solutions across hundreds of large global customers.

Global enterprises will benefit from the combined strengths of Uniphore’s enterprise-grade AI solutions and Konecta’s expertise in business transformation. By merging advanced AI with operational excellence, this collaboration is set to reshape customer service delivery, generating actionable insights that drive real value. Clients can expect improved ROI through enhanced Net Promoter Scores (NPS), faster resolution times, and reduced operational costs, enabling them to achieve greater efficiency and impactful customer engagement.

“The partnership between Uniphore and Konecta is significant because this is the first time the end-to-end Enterprise AI stack from Uniphore is coming together with Konecta’s industry-leading domain and consulting expertise. Together, they will power the digital transformation using Gen AI that most enterprises around the world need,” said Umesh Sachdev, CEO and Co-founder of Uniphore. “I couldn’t be more excited to work alongside such a forward-thinking and results-focused organization.”

This partnership marks a pivotal step in Konecta’s journey to becoming a top-tier Gen AI services provider, combining its hybrid model of human and virtual agents to deliver innovative customer solutions. By integrating Uniphore’s cutting-edge AI technology, Konecta will enhance its service offerings with hyper-personalized interactions powered by real-time emotion detection and sentiment analysis tools that dynamically adapt to customer needs. This powerful alliance positions Konecta at the forefront of CX automation, empowering the company to set new standards in delivering seamless, AI-driven customer experiences.

“Our partnership with Uniphore represents a significant step forward in our commitment to deliver AI-led transformation for our clients,” said Nourdine Bihmane, CEO of Konecta. “By combining Uniphore’s cutting-edge AI technology with Konecta’s operational expertise, we will provide unmatched service, operational efficiency, and innovation. We are excited to see how this alliance will help our clients achieve new levels of business success through AI-powered customer engagement.”

As part of this alliance, Konecta and Uniphore will pursue a joint go-to-market strategy with an ambition to generate $500 million in revenue over the next five years, with a key focus on disrupting the U.S. and UK market. To support this goal, Konecta will serve as Uniphore’s preferred professional services partner globally, implementing and integrating Uniphore’s U-Platform, which includes U-Assist, U-Analyze and U-Self Serve solutions on behalf of Uniphore.

Through this alliance, Konecta and Uniphore will co-develop specialized Gen AI solutions. Leveraging Uniphore’s newly launched knowledge-as-a-service solution, X-Stream, Konecta will create proprietary, industry-specific small language models (SLMs) to address unique industry challenges with unmatched precision and adaptability. As part of this effort, Konecta’s Gen AI-based co-pilot, supporting 12 languages, will be deployed across its contact centers, empowering agents with real-time, context-aware support. This capability, already live with several of Konecta’s key clients, will expand to serve the majority of clients within the next 12 months, positioning Konecta as a leader in delivering industry-specific AI solutions with speed and precision.

Konecta expects to see an immediate impact from this alliance, particularly in customer satisfaction and agent productivity while offering new Digital Agents besides Human agents on the same platform in a hybrid model. Working together, Konecta and Uniphore will develop AI capabilities focused on proactive service, enabling businesses to anticipate and resolve customer needs before issues arise. Furthermore, the partnership will streamline support tools for agents, improving service quality and driving operational gains from day one.



 Àüü´º½º¸ñ·ÏÀ¸·Î

PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
IRIS2 lifts off as European Commission and SpaceRISE sign contract in Brussels
HistoSonics Edison¢ç Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
Novotech Named a Fierce CRO Award Winner in the Excellence
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
The Next Gen of AI Awaits, GIGABYTE Sets the Benchmark for HPC at CES 2025
SpaceRISE Signs Concession Contract to Deliver Europe¡¯s IRIS©÷ Connectivity Network

 

Boomi Boosts Data Management Capabilities With Acquisition of Modern D...
Korean Robotaxi Startup Sonnet.AI Secures Level 4 Autonomous Shuttles ...
KIOXIA NVMe SSD Cryptographic Module Achieves FIPS 140-3 Level 2 Valid...
CHMP Recommends Approval of Galderma¡¯s Nemolizumab for Moderate-to-Se...
BrightPath Bio and Cellistic Announced Process Development and Manufac...
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engi...
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Tria...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..